Ophthalmology – Toxic Keratoconjunctivitis

What the Disorder Represents

Toxic keratoconjunctivitis is an inflammatory and epithelial ocular-surface reaction caused by direct toxicity from a topical medication, preservative, contact lens product, cosmetic, chemical, or environmental irritant.

It may involve:

• Bulbar conjunctiva
• Palpebral conjunctiva
• Corneal epithelium
• Eyelid/periocular skin

A commonly used related term is:

Toxic medicamentosa

when the reaction results from repeated topical ophthalmic therapy.

How the Injury Develops

The main mechanism is usually:

Direct epithelial toxicity and ocular-surface inflammation

rather than a classic antigen-specific allergic reaction.

Toxic substances can disrupt:

• Corneal epithelial cells
• Conjunctival epithelial cells
• Goblet cells
• Tear-film stability

Chronic exposure may produce:

Epithelial breakdown → inflammation → tear-film dysfunction → additional epithelial toxicity

creating a self-perpetuating cycle.

Toxic vs Allergic Reactions

These mechanisms frequently overlap.

Toxic Reaction

Usually related to:

• Concentration
• Frequency
• Duration of exposure
• Preservative load

and commonly produces:

• Burning
• Diffuse punctate keratopathy
• Conjunctival injection

Allergic/Delayed Hypersensitivity Reaction

More likely to produce:

• Itching
• Eyelid dermatitis
• Follicular or papillary conjunctivitis
• Periocular edema

Some topical medications can produce:

Both toxic and allergic ocular-surface disease.

Common Medication Causes

Frequently implicated topical medications include:

• Brimonidine
• Apraclonidine
• Aminoglycosides such as gentamicin and tobramycin
• Neomycin-containing preparations
• Antiviral drops such as trifluridine
• Chronic topical anesthetic misuse
• Multiple glaucoma medications

Risk rises when several drops are used simultaneously.

Why Glaucoma Patients Are Particularly Vulnerable

Patients with glaucoma may use several topical agents for years.

Chronic exposure can produce:

• Tear-film instability
• Conjunctival inflammation
• Superficial punctate keratitis
• Meibomian gland dysfunction
• Conjunctival fibrosis

The problem is frequently related as much to:

Preservative exposure

as to the active medication itself.

Benzalkonium Chloride Toxicity

Benzalkonium chloride (BAK) is one of the most important ophthalmic preservatives associated with chronic ocular-surface toxicity.

Repeated exposure can cause:

• Epithelial cell injury
• Reduced goblet-cell density
• Tear-film instability
• Conjunctival inflammation
• Corneal punctate epitheliopathy

Risk increases with:

• Higher concentrations
• More frequent dosing
• Multiple preserved medications
• Long treatment duration

Modern Prevention Strategy

When chronic topical therapy is necessary, reduce preservative burden when possible by using:

• Preservative-free formulations
• Lower-frequency regimens
• Fixed-combination drops
• Non-BAK-preserved preparations

This is particularly important in patients with:

• Dry eye
• Ocular surface disease
• Prior corneal surgery
• Long-term glaucoma treatment

Contact Lens–Associated Toxicity

Toxic keratoconjunctivitis may occur from:

• Contact lens disinfectants
• Cleaning solutions
• Preservatives
• Improperly neutralized hydrogen peroxide
• Chemical contamination of a lens
• Lens overwear

Typical findings include:

• Burning after lens insertion
• Diffuse punctate epithelial staining
• Redness
• Contact lens intolerance

Hydrogen Peroxide Lens Injury

Failure to fully neutralize a hydrogen peroxide contact lens system can cause an acute:

Chemical epithelial injury

with:

• Severe burning
• Tearing
• Conjunctival injection
• Diffuse corneal epithelial staining

The lens should be removed immediately and the ocular surface irrigated if exposure is recent.

Cosmetic and Periocular Causes

Possible triggers include:

• Eye makeup
• Eyelash adhesives
• Cosmetic removers
• Facial creams
• Hair products
• Eyelid cleansers
• Aerosols

The history should specifically address newly introduced products.

Environmental Irritants

Examples include:

• Smoke
• Chlorine
• Air pollution
• Solvents
• Chemical fumes
• Industrial exposures

Significant chemical exposure should be treated as:

Acute chemical ocular injury

rather than routine medicamentosa.

Typical Symptoms

Patients commonly report:

• Burning
• Stinging
• Foreign-body sensation
• Redness
• Tearing
• Photophobia
• Fluctuating vision

Itching can occur but, when dominant, should raise suspicion for an allergic component.

Clues From the Timing

Symptoms may develop:

• Shortly after a new topical product
• Gradually after repeated exposure
• After increasing drop frequency
• After adding another medication

Chronic medicamentosa can be missed because the offending agent may have been used for:

Weeks or months before symptoms become obvious.

Conjunctival Findings

The conjunctiva may show:

• Diffuse injection
• Follicular reaction
• Papillary reaction
• Chemosis
• Inferior fornix inflammation

The exact appearance depends on the offending agent and whether hypersensitivity coexists.

Corneal Findings

Typical corneal changes include:

• Superficial punctate epithelial keratitis
• Diffuse fluorescein staining
• Epithelial irregularity
• Reduced tear-film stability

More severe toxicity may produce:

• Larger epithelial defects
• Delayed epithelial healing

Follicular Conjunctivitis From Medications

A chronic follicular response is particularly associated with:

• Brimonidine
• Apraclonidine
• Certain antivirals
• Other chronic topical medications

Follicles are often most prominent in the:

Inferior fornix and palpebral conjunctiva.

Eyelid and Periocular Findings

Associated signs may include:

• Eyelid erythema
• Periocular dermatitis
• Edema
• Scaling

These findings increase suspicion for:

Contact allergy or hypersensitivity

rather than pure direct toxicity.

An Important Modern Correction About Molluscum

Older descriptions sometimes listed periocular molluscum contagiosum under toxic keratoconjunctivitis.

This is misleading.

Molluscum causes a:

Chronic infectious follicular conjunctivitis

because viral proteins shed from the eyelid lesion onto the ocular surface.

It is not primarily a toxic medicamentosa.

The classic eyelid lesion is:

• Small
• Dome-shaped
• Pearly
• Umbilicated

How Molluscum-Associated Conjunctivitis Is Managed

Treatment is directed at the eyelid lesion rather than topical anti-inflammatory therapy alone.

Options include:

• Curettage
• Excision
• Other lesion-directed dermatologic therapy

Conjunctivitis usually resolves once the lesion is eliminated.

How the Diagnosis Is Made

Diagnosis is mainly:

Clinical

and depends on recognizing the temporal relationship between symptoms and an offending exposure.

The most useful diagnostic step is often:

Removing the suspected culprit and observing for improvement.

Important History Questions

Ask about:

• Every prescription eye drop
• Over-the-counter eye drops
• Artificial tears
• Contact lens solutions
• Cosmetic products
• Eyelid cleansers
• Occupational chemical exposure
• Frequency and duration of use
• Recent change in formulation or manufacturer

Patients may overlook nonprescription products unless specifically asked.

Fluorescein Examination

Fluorescein may reveal:

• Diffuse punctate epithelial staining
• Confluent epithelial disease
• Larger defects in severe cases

The staining pattern can help distinguish toxicity from:

• Exposure
• Dry eye
• Infectious keratitis

Laboratory Testing

Routine laboratory testing is:

Not required

in typical toxic keratoconjunctivitis.

Cultures or corneal scraping should be considered when there is concern for:

Infectious keratitis.

Important Diagnostic Alternatives

The differential diagnosis includes:

• Viral conjunctivitis
• Allergic conjunctivitis
• Bacterial conjunctivitis
• Dry eye disease
• Blepharitis
• Contact lens overwear
• Exposure keratopathy
• Adenoviral keratoconjunctivitis
• Early microbial keratitis

Distinguishing It From Viral Conjunctivitis

Viral disease more commonly produces:

• Acute contagious onset
• Follicular conjunctivitis
• Preauricular lymphadenopathy
• Watery discharge
• Recent sick contact

Toxic disease is more strongly associated with:

Medication or chemical exposure.

Distinguishing It From Allergic Conjunctivitis

Allergy typically produces:

• Prominent itching
• Papillary response
• Eyelid edema
• Stringy mucus

Toxicity more commonly produces:

• Burning
• Stinging
• Diffuse epithelial keratopathy

Overlap is common.

Distinguishing It From Dry Eye

Dry eye may cause similar:

• Burning
• Punctate staining
• Fluctuating vision

but toxic keratoconjunctivitis often has a clear relationship to:

Topical medication or chemical exposure.

Chronic toxic exposure can itself cause or worsen dry eye.

Distinguishing It From Microbial Keratitis

Urgent concern for infectious keratitis is warranted with:

• Focal stromal infiltrate
• Significant epithelial defect
• Increasing pain
• Marked photophobia
• Anterior chamber reaction
• Reduced vision

This is especially important in:

Contact lens wearers.

First Treatment Priority

The key intervention is:

Identify and remove the offending agent.

This may involve:

• Stopping a nonessential medication
• Switching to a preservative-free formulation
• Changing contact lens solution
• Stopping cosmetic products
• Avoiding environmental exposure

Do Not Simply Stop Essential Glaucoma Therapy

If a glaucoma medication is suspected, treatment should be modified in coordination with the treating eye-care clinician.

Options include:

• Switching drug class
• Preservative-free formulation
• Fixed-combination therapy
• Laser treatment such as SLT in appropriate patients

Abruptly stopping all glaucoma therapy can result in:

Dangerous IOP elevation.

Lubrication

First-line supportive treatment includes:

• Preservative-free artificial tears
• Lubricating gel
• Nighttime ointment when needed

Preservative-free products are preferred because adding additional preservative exposure can worsen the problem.

Contact Lens Holiday

Contact lenses should generally be discontinued until:

• Corneal staining resolves
• Conjunctival inflammation improves
• Symptoms settle

Before resuming lens wear, reconsider:

• Lens fit
• Replacement schedule
• Cleaning system
• Contact lens hygiene

Role of Topical Corticosteroids

A short course of a mild topical corticosteroid may be useful when inflammation is substantial and the offending agent has already been removed.

Examples include:

• Loteprednol
• Fluorometholone

Steroids should be prescribed only after:

Infectious keratitis has been reasonably excluded.

Why Steroids Need Monitoring

Topical corticosteroids can cause:

• Ocular hypertension
• Steroid-induced glaucoma
• Cataract
• Delayed epithelial healing
• Worsening of undiagnosed infection

Longer courses require:

IOP monitoring.

Role of Steroid-Sparing Therapy

Patients with chronic ocular surface inflammation after removal of the toxic exposure may occasionally benefit from:

• Topical cyclosporine
• Lifitegrast
• Other dry-eye anti-inflammatory therapies

These are not primary treatment for acute toxicity but may help when significant:

Secondary inflammatory dry eye

persists.

Severe Epithelial Toxicity

More significant corneal epithelial injury may require:

• Frequent preservative-free lubrication
• Ointment
• Temporary bandage contact lens in selected cases
• Close corneal follow-up

Persistent defects should trigger reassessment for:

• Neurotrophic keratopathy
• Infection
• Limbal stem-cell injury
• Continued toxic exposure

Toxicity From Topical Anesthetic Abuse

Repeated topical anesthetic use can cause a particularly severe toxic keratopathy.

Findings may include:

• Persistent epithelial defect
• Stromal infiltrates
• Ring infiltrate
• Corneal melt

This can mimic infection and may lead to:

Permanent visual loss or perforation.

The anesthetic must be stopped immediately.

When Urgent Referral Is Needed

Urgent ophthalmic assessment is appropriate when there is:

• Reduced vision
• Significant pain
• Photophobia
• Stromal infiltrate
• Large epithelial defect
• Corneal thinning
• Contact lens-associated keratitis
• Failure to improve after removal of the suspected agent

Expected Time to Improvement

Mild toxic medicamentosa often begins improving within:

Several days after removing the offending exposure.

More chronic disease may require:

• Weeks
• Occasionally longer

for the ocular surface to recover fully.

Follow-Up Approach

Follow-up depends on severity.

Mild disease may be reviewed after:

• Several days to 1–2 weeks

Closer review is necessary when there is:

• Significant corneal involvement
• Steroid treatment
• Glaucoma therapy modification
• Persistent epithelial disease

What to Monitor

Follow:

• Visual acuity
• Corneal staining
• Conjunctival inflammation
• Epithelial healing
• IOP when steroids are used
• IOP if glaucoma medications have been modified

Expected Outcome

The prognosis is generally:

Excellent

when the toxic agent is identified and removed promptly.

The ocular surface usually returns toward baseline without permanent visual impairment.

When Permanent Damage Can Occur

Chronic or severe toxicity may occasionally cause:

• Persistent epithelial disease
• Corneal scarring
• Limbal stem-cell dysfunction
• Secondary dry eye
• Reduced vision

Severe injury is particularly associated with:

• Chemical burns
• Topical anesthetic abuse
• Prolonged exposure to highly toxic preparations

High-Yield Takeaways

• Toxic keratoconjunctivitis is an ocular-surface inflammatory and epithelial reaction caused by direct toxicity from medications, preservatives, contact lens products, cosmetics, or environmental irritants.
• Chronic topical ophthalmic therapy can produce toxic medicamentosa, particularly when multiple preserved drops are used.
• Benzalkonium chloride (BAK) is an important cause of chronic epithelial and conjunctival toxicity.
• Typical symptoms are burning, stinging, foreign-body sensation, redness, tearing, and fluctuating vision.
• Common signs include diffuse conjunctival injection, follicular or papillary reaction, and superficial punctate keratitis.
• Brimonidine and apraclonidine are particularly associated with chronic follicular conjunctivitis.
• Contact lens solutions can cause toxic epitheliopathy; inadequately neutralized hydrogen peroxide can cause an acute chemical ocular-surface injury.
• Periocular molluscum contagiosum causes infectious follicular conjunctivitis rather than true toxic keratoconjunctivitis.
• Diagnosis is primarily clinical and depends heavily on identifying the offending exposure.
• The cornerstone of treatment is removal or substitution of the causative agent.
• In glaucoma patients, do not simply discontinue pressure-lowering therapy; consider preservative-free alternatives, different drug classes, or other IOP-lowering strategies.
• Preservative-free artificial tears are the preferred supportive treatment.
• A contact lens holiday is appropriate until corneal and conjunctival inflammation resolves.
• Short-course topical corticosteroids may be useful for substantial inflammation, but only after infectious keratitis has been excluded.
• Significant pain, visual decline, a focal stromal infiltrate, or a large epithelial defect should prompt urgent evaluation for microbial keratitis or severe toxic injury.
• Topical anesthetic abuse can cause severe corneal toxicity, melting, and perforation and must be recognized promptly.
• Most cases resolve with removal of the offending exposure, and the overall visual prognosis is excellent.